Latest Wellcome Trust Sanger Institute Stories
A new study into osteosarcoma - cancer of the bone - will use advances in genomic research and analysis to identify new genes that give rise to the condition and to create personalised blood tests for children and young adults with the condition.
A detailed analysis of data from 185 human genomes sequenced in the course of the 1000 Genomes Project, by scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany, in collaboration with researchers at the Wellcome Trust Sanger Institute in Cambridge, UK, as well as the University of Washington and Harvard Medical School, both in the USA, has identified the genetic sequence of an unprecedented 28 000 structural variants (SVs) â€“ large portions of the human...
Advances in DNA sequencing technology have revolutionized biomedical research and taken us another step forward in personalized medicine.
New research provides the first detailed genetic picture of an evolutionary war between Streptococcus pneumoniae bacteria and the vaccines and antibiotics used against it over recent decades.
Remarkable new research overthrows the conventional view that cancer always develops in a steady, stepwise progression.
A set of brain proteins is found to play a role in over 100 brain diseases and provides a new insight into evolution of behavior.
Researchers unveiled early results from the pilot phase of the 1000 Genomes Project on Wednesday, revealing the most complete inventory to date of the millions of DNA variations between individuals.
In new research published today, researchers uncover evolution in action in cancer cells.
Researchers have developed a genetic tool in mice to speed the discovery of novel genes involved in cancer.
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom.
- A transitional zone between two communities containing the characteristic species of each.